CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,000 shares at $14.68 ($29,360)
- 4 Open-market sale Chief Executive Officer sold 162,500 shares at an average $14.71 ($2,390,000)
- 4 Open-market sale Chief Operating Officer sold 28,336 shares at an average $15.05 ($426,383)
- 4 Open-market sale Chief Operating Officer sold 45,049 shares at an average $12.03 ($541,719)
- 4 Open-market sale CFO sold 30,000 shares at $10.02 ($300,558)
- 4 Option exercise Director acquired 4,274 shares (option exercise)
- 4 Open-market sale Director sold 961 shares at $9.48 ($9,110)
- 4 Open-market sale Director sold 2,750 shares at $9.00 ($24,750)
- 4 Gift Chief Executive Officer gave 10,000 shares (gift)
- 4 Open-market sale CFO sold 20,000 shares at $10.69 ($213,706)
- 4 Open-market sale Director sold 17,500 shares at $10.71 ($187,352)
- 4 Option exercise Director acquired 4,090 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 19,466 shares at $9.75 ($189,794)
- 4 Open-market sale Chief Scientific Officer sold 19,467 shares at $19.06 ($371,004)
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at $21.13 ($2,113,450)
- 4 Open-market sale CFO sold 35,000 shares at $24.95 ($873,208)
Page 9 of 30 · 592 filings